VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+2.93%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$182M
AUM Growth
+$182M
(-5.1%)
Cap. Flow
-$9.35M
Cap. Flow
% of AUM
-5.14%
Top 10 Holdings %
Top 10 Hldgs %
6.2%
Holding
508
New
65
Increased
160
Reduced
215
Closed
68
Top Buys
| 1 |
Dow Inc
DOW
|
$1.16M |
| 2 |
Hershey
HSY
|
$1.04M |
| 3 |
Copart
CPRT
|
$1.03M |
| 4 |
lululemon athletica
LULU
|
$1.02M |
| 5 |
Progressive
PGR
|
$999K |
Top Sells
| 1 |
Lennar Class A
LEN
|
$952K |
| 2 |
TJX Companies
TJX
|
$909K |
| 3 |
Ameriprise Financial
AMP
|
$902K |
| 4 |
Abbott
ABT
|
$892K |
| 5 |
Home Depot
HD
|
$885K |
Sector Composition
| 1 | Healthcare | 25.65% |
| 2 | Financials | 14.09% |
| 3 | Technology | 11.21% |
| 4 | Energy | 10.21% |
| 5 | Materials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Immunocore
IMCR
$1.78B
| $258K | 0.14% |
5,227
+96
| +2% | +$4.75K |
|
277
Gerdau
GGB
$6.05B
| $258K | 0.14% |
62,879
-48,737
| -44% | -$200K |
|
|
BSL
278
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$186M
| $258K | 0.14% |
20,361
-4,269
| -17% | -$54.1K |
|
|
TSVT
279
DELISTED
2seventy bio
TSVT
| $255K | 0.14% |
25,042
+444
| +2% | +$4.53K |
|
|
SBR
280
Sabine Royalty Trust
SBR
$1.09B
| $255K | 0.14% |
+3,555
| New | +$255K |
|
281
CVR Partners
UAN
$932M
| $253K | 0.14% |
+2,836
| New | +$253K |
|
282
Alexandria Real Estate Equities
ARE
$13.9B
| $253K | 0.14% |
+2,013
| New | +$253K |
|
|
EVF
283
Eaton Vance Senior Income Trust
EVF
$101M
| $251K | 0.14% |
46,947
-8,089
| -15% | -$43.3K |
|
284
United Therapeutics
UTHR
$17.7B
| $249K | 0.14% |
1,113
+20
| +2% | +$4.48K |
|
285
Main Street Capital
MAIN
$5.87B
| $249K | 0.14% |
6,300
-358
| -5% | -$14.1K |
|
286
Braskem
BAK
$1.33B
| $248K | 0.14% |
+32,247
| New | +$248K |
|
287
GeoPark
GPRK
$322M
| $248K | 0.14% |
+21,857
| New | +$248K |
|
288
Amylyx Pharmaceuticals
AMLX
$877M
| $248K | 0.14% |
8,460
+153
| +2% | +$4.49K |
|
289
Saratoga Investment
SAR
$401M
| $246K | 0.14% |
9,750
-25
| -0.3% | -$632 |
|
|
XIFR
290
XPLR Infrastructure, LP
XIFR
$975M
| $245K | 0.13% |
+4,027
| New | +$245K |
|
291
KT
KT
$9.63B
| $238K | 0.13% |
21,004
-12,415
| -37% | -$141K |
|
292
Axsome Therapeutics
AXSM
$6.09B
| $238K | 0.13% |
3,860
+65
| +2% | +$4.01K |
|
293
Cheniere Energy
CQP
$26B
| $237K | 0.13% |
5,007
-2,731
| -35% | -$129K |
|
294
Protagonist Therapeutics
PTGX
$3.62B
| $237K | 0.13% |
10,286
-3,949
| -28% | -$90.8K |
|
295
BioCryst Pharmaceuticals
BCRX
$1.74B
| $230K | 0.13% |
27,571
+485
| +2% | +$4.05K |
|
|
IMGN
296
DELISTED
Immunogen Inc
IMGN
| $229K | 0.13% |
59,573
+1,052
| +2% | +$4.04K |
|
297
Agios Pharmaceuticals
AGIO
$2.36B
| $228K | 0.13% |
9,932
+179
| +2% | +$4.11K |
|
298
Moderna
MRNA
$9.36B
| $226K | 0.12% |
1,472
+24
| +2% | +$3.69K |
|
299
Medical Properties Trust
MPW
$2.66B
| $225K | 0.12% |
27,373
-5,701
| -17% | -$46.9K |
|
|
CTIC
300
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $220K | 0.12% |
52,472
+930
| +2% | +$3.91K |
|